The diagnostic challenge of patients with anti-U1-RNP antibodies
Abstract Anti-U1-RNP antibodies are necessary for the diagnosis of mixed connective tissue disease (MCTD), but they are also prevalent in other connective tissue diseases, especially systemic lupus erythematosus (SLE), from which distinction remains challenging. We aimed to describe the presentation and outcome of patients with anti-U1-RNP antibodies and to identify factors to distinguish MCTD from SLE. We retrospectively applied the criteria sets for MCTD, SLE, systemic sclerosis (SSc) and rheumatoid arthritis (RA) to all patients displaying anti-U1-RNP antibodies in the hospital of Caen from 2000 to 2020. Thirty-six patients were included in the analysis. Eighteen patients (50%) satisfied at least one of the MCTD classifications, 11 of whom (61%) also met 2019 ACR/EULAR criteria for SLE. Twelve other patients only met SLE without MCTD criteria, and a total of 23 patients (64%) met SLE criteria. The most frequent manifestations included Raynaud’s phenomenon (RP, 91%) and arthralgia (67%). We compared the characteristics of patients meeting only the MCTD (n = 7), SLE (n = 12), or both (n = 11) criteria. Patients meeting the MCTD criteria were more likely to display SSc features, including sclerodactyly (p < 0.01), swollen hands (p < 0.01), RP (p = 0.04) and esophageal reflux (p < 0.01). The presence of scleroderma features (swollen hands, sclerodactyly, gastro-oesophageal reflux), was significantly associated with the diagnosis of MCTD. Conversely, the absence of those manifestations suggested the diagnosis of another definite connective tissue disease, especially SLE..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Rheumatology international - 43(2022), 3 vom: 27. Juli, Seite 509-521 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Elhani, Ines [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Anti-U1-RNP antibodies |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 |
|---|
| doi: |
10.1007/s00296-022-05161-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR049455303 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR049455303 | ||
| 003 | DE-627 | ||
| 005 | 20230510064052.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00296-022-05161-w |2 doi | |
| 035 | |a (DE-627)SPR049455303 | ||
| 035 | |a (SPR)s00296-022-05161-w-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Elhani, Ines |e verfasserin |0 (orcid)0000-0002-9767-2262 |4 aut | |
| 245 | 1 | 4 | |a The diagnostic challenge of patients with anti-U1-RNP antibodies |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 | ||
| 520 | |a Abstract Anti-U1-RNP antibodies are necessary for the diagnosis of mixed connective tissue disease (MCTD), but they are also prevalent in other connective tissue diseases, especially systemic lupus erythematosus (SLE), from which distinction remains challenging. We aimed to describe the presentation and outcome of patients with anti-U1-RNP antibodies and to identify factors to distinguish MCTD from SLE. We retrospectively applied the criteria sets for MCTD, SLE, systemic sclerosis (SSc) and rheumatoid arthritis (RA) to all patients displaying anti-U1-RNP antibodies in the hospital of Caen from 2000 to 2020. Thirty-six patients were included in the analysis. Eighteen patients (50%) satisfied at least one of the MCTD classifications, 11 of whom (61%) also met 2019 ACR/EULAR criteria for SLE. Twelve other patients only met SLE without MCTD criteria, and a total of 23 patients (64%) met SLE criteria. The most frequent manifestations included Raynaud’s phenomenon (RP, 91%) and arthralgia (67%). We compared the characteristics of patients meeting only the MCTD (n = 7), SLE (n = 12), or both (n = 11) criteria. Patients meeting the MCTD criteria were more likely to display SSc features, including sclerodactyly (p < 0.01), swollen hands (p < 0.01), RP (p = 0.04) and esophageal reflux (p < 0.01). The presence of scleroderma features (swollen hands, sclerodactyly, gastro-oesophageal reflux), was significantly associated with the diagnosis of MCTD. Conversely, the absence of those manifestations suggested the diagnosis of another definite connective tissue disease, especially SLE. | ||
| 650 | 4 | |a Mixed connective tissue disease |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Systemic lupus erythematosus |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Anti-U1-RNP antibodies |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Connective tissue disease |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Khoy, Kathy |0 (orcid)0000-0002-7021-1415 |4 aut | |
| 700 | 1 | |a Mariotte, Delphine |0 (orcid)0000-0002-9989-4272 |4 aut | |
| 700 | 1 | |a Comby, Elisabeth |4 aut | |
| 700 | 1 | |a Marcelli, Christian |0 (orcid)0000-0002-9699-2467 |4 aut | |
| 700 | 1 | |a Le Mauff, Brigitte |0 (orcid)0000-0001-9242-4895 |4 aut | |
| 700 | 1 | |a Audemard-Verger, Alexandra |0 (orcid)0000-0002-0226-5016 |4 aut | |
| 700 | 1 | |a Boutemy, Jonathan |4 aut | |
| 700 | 1 | |a Maigné, Gwénola |0 (orcid)0000-0002-3023-361X |4 aut | |
| 700 | 1 | |a Martin Silva, Nicolas |0 (orcid)0000-0002-1536-1373 |4 aut | |
| 700 | 1 | |a Aouba, Achille |0 (orcid)0000-0003-1726-3811 |4 aut | |
| 700 | 1 | |a de Boysson, Hubert |0 (orcid)0000-0001-9083-8365 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rheumatology international |d Berlin : Springer, 1981 |g 43(2022), 3 vom: 27. Juli, Seite 509-521 |w (DE-627)SPR00382473X |w (DE-600)1464208-6 |x 1437-160X |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2022 |g number:3 |g day:27 |g month:07 |g pages:509-521 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00296-022-05161-w |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2022 |e 3 |b 27 |c 07 |h 509-521 | ||